학술논문

Prior flavivirus immunity skews the yellow fever vaccine response to cross-reactive antibodies with potential to enhance dengue virus infection.
Document Type
Article
Source
Nature Communications; 2/27/2024, Vol. 15 Issue 1, p1-17, 17p
Subject
DENGUE viruses
YELLOW fever
VIRUS diseases
VACCINE effectiveness
TICK-borne encephalitis viruses
ZIKA virus infections
FENITROTHION
Language
ISSN
20411723
Abstract
Copyright of Nature Communications is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)